An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia On April 30, Amylyx Pharmaceuticals, Inc. announced that the first participant has been dosed in the pivotal Phase 3 LUCIDITY clinical trial of avexitide, an investigational, first-in-class glucagon-like...
Author: Mark Newman
Endocrine Society is Advocating for You We know this has been an extraordinary turbulent and disruptive time for U.S. researchers and our colleagues around the world. Since January, there have been a myriad of U.S. executive actions affecting researchers, including cuts to research, firing of federal workers, rescinded grants, and withdrawn funding opportunities. In early...
We Urge U.S. Lawmakers to Restore NIH Funding and Diabetes Prevention Program Let’s not sugar coat the situation: Biomedical research funding in the United States has taken a significant hit in recent months. Deep budget cuts and staff layoffs at the National Institutes of Health (NIH) threaten not only the livelihoods of our many research... A Game-Changer in Osteoporosis and Fracture Prevention On behalf of Endocrine Society’s Bone and Mineral Special Interest Group Steering Committee, Vafa Tabatabaie, MD, and Muriel Babey, MD, discuss the importance of fracture liaison services, how they can contribute to an improved quality of life for the patients as well as cost savings for the facility,...
They are insidious and it seems like there’s no escape from them no matter what your age, race, or where you live. I’m talking about endocrine-disrupting chemicals (EDCs) found in an unending number of household and environmental items and cause often irreparable damage to the endocrine system. Therefore, this issue of Endocrine News is devoted... Lori Raetzman, PhD, discusses mentoring and conducting science in challenging times. When she’s not in her lab studying the effects of environmental chemicals on female reproductive aging, Lori T. Raetzman, PhD, is busy guiding the next generation of endocrine scientists, which makes her an ideal candidate to receive the Endocrine Society’s 2025 Sydney Ingber Award...
The Endocrine Society has selected Yoshitomo Hoshino, MD, PhD, as the recipient of its 2025 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne...
The Endocrine Society has appointed Manuel Tena-Sempere, MD, PhD, of the University of Cordoba in Spain, as the next editor-in-chief of its flagship basic science journal, Endocrinology, starting January 2026. Manuel Tena-Sempere is a professor of physiology at the University of Cordoba, a research group leader at the biomedical research institute of Cordoba (IMIBIC) and...
